← Evidence map

ArticleCancer letters2019

Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.

Ning Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

55 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 30315846